Navigation Links
Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
Date:1/23/2010

ith non-ST-segment elevation acute coronary syndrome (NSTE-ACS). The randomized study with 60 patients compared the Genous Bio-engineered R stent with bare metal stents with concomitant high dose atorvastatin in the reduction of neointimal hyperplasia assessed by coronary angiography and IVUS after six months.

In the JACK-EPC trial, the Genous Bio-engineered R stent induced less neointimal hyperplasia and a lower binary restenosis rate of 13 percent in the Genous Bio-engineered R stent, compared to 26.6 percent in the control group. Importantly, the major adverse cardiac events (MACE) rate was reported at only 10 percent in the Genous Bio-engineered R stent treated patient group versus 16 percent in the bare metal stent treated group.

"In our small study, we observed a lower amount of neointimal proliferation with the EPC capture stent compared to the bare metal stent control," said Wojakowski.  "Good safety is indicated by comparable stent thrombosis.  We think this makes the Genous stent a very promising treatment strategy for ACS patients, especially those with high risk of bleeding or not eligible for prolonged dual antiplatelet therapy due to allergy to ASA or clopidogrel."

"Data from both presentations support the use of the Genous Bio-engineered R stent as an effective treatment option in what interventional cardiologists find to be challenging cases," said Al Novak, OrbusNeich's chairman and CEO. "We look forward to continuing to work with physicians to realize the full potential of the Genous technology."

About Genous  

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devices such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams Pre-Clinical Development of Neuroprotective Parkinsons Therapies
2. Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
3. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
4. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
5. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
6. Enbrel Will Remain Decision Resources Clinical Gold Standard Through 2018 for the Treatment of Rheumatoid Arthritis
7. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
8. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
9. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
10. New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants
11. DATATRAKs eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  Strategic Health Services, Inc. (SHS), a ... announced a strategic agreement with QualCare, Inc., a leading provider ... regional marketplace.  This agreement will further QualCare,s ... wellness solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 ...
(Date:12/17/2014)... MILAN , December 17, 2014 ... becoming nothing less than a hub of information concerning the ... A further addition to the recently launched ... world and has now been enriched by a new chapter ... A richly detailed and panoramic hub on ...
(Date:12/17/2014)... and RALEIGH, N.C. ... Marketing Communications, LLC (CTMC), and Integrated Clinical Trial ... recruitment and retention for clinical trials announce that ... Clinical Trial Marketing Services (i-CTMS). i-CTMS will provide ... services to pharmaceutical, biotechnology and medical device companies. ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... Regenicin , Inc. (OTC Bulletin Board: RGIN ) ... therapies to restore the health of damaged tissues and organs, ... 1st Annual LifeTech Investor Conference at the JW Marriott Marquis ... Regenicin,s core concept and business model for bringing regenerative medicine ...
... Trimega Laboratories is pleased to announce that it has been ... Investors in People (IIP) Standard. Its accreditation ... IIP and reflects the commitment and hard work undertaken by ... achievement is that, as a substance abuse testing ...
Cached Medicine Technology:Regenicin CEO to Speak at LifeTech Investor Conference in Miami, Florida November 12th, 2010 2IIP Recognition for Substance Abuse Testing Lab Trimega Laboratories 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Use ... device and length of time indoor tanning is used, according to a report in Cancer ... ... Cancer Research Hosted Press Conference on Findings, , ,(recording available below) , , , ...
... worked in people and pigs in study, but more ... A new approach to treating irregular heartbeats appears to ... both patients and pigs, new research indicates. , In ... laser-balloon catheter" -- enables doctors to much more accurately ...
... oral hygiene and cardiovascular disease , THURSDAY, May 27 ... teeth regularly: People who don,t perform this essential of ... heart disease compared to their more diligent peers. ... toothbrushing frequency and both cardiovascular disease and inflammatory markers ...
... , ... Dallas Salutes Ten Years of Continuous Addiction Treatment Services! , ... Dallas, Texas (PRWEB) -- Surrounded by friends ... “We look forward to ten more years” sings Dallas native Don Fielding, owner and ...
... ,central line, catheter-linked illnesses fall 18 percent across the ... across the United States are seeing a decrease of ... necks, called central line catheters, a new report finds. ... and public health problem in the United States," Dr. ...
... Science University is partnering with the University of Oregon and ... and existing drugs and compounds that may prevent the complications ... to bone marrow failure and cancer. With a new ... Institute, a branch of the NIH, the research teams will ...
Cached Medicine News:Health News:Indoor Tanning Beds Increase Risk of Melanoma 2Health News:Indoor Tanning Beds Increase Risk of Melanoma 3Health News:Indoor Tanning Beds Increase Risk of Melanoma 4Health News:Laser Used to Blast Away Cells Causing Irregular Heartbeat 2Health News:Toothbrushing May Stave Off Heart Woes 2Health News:Addiction and Recovery: Life Force Dallas 2Health News:Addiction and Recovery: Life Force Dallas 3Health News:Addiction and Recovery: Life Force Dallas 4Health News:Decline in Potentially Lethal Hospital-Based Infections 2Health News:Decline in Potentially Lethal Hospital-Based Infections 3Health News:OHSU joins forces with UO, Harvard to accelerate Fanconi anemia research 2Health News:OHSU joins forces with UO, Harvard to accelerate Fanconi anemia research 3
... Field (PEMF) bone growth stimulation delivered by ... long bone and small bone nonunions. Physio-Stim ... brace, or clothing without lessening its effectiveness. ... compact, lightweight unit including success rates as ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Screws. Optimal screw design ... selection options. Robust threads ... and chamfered screw hub ... tissue fixation. Features a ...
Cannulated Interference Screws...
Medicine Products: